What is KLRS's dilution risk score?

KLRS has a latest available DilutionScore record of 73/100, categorized as high dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for KLRS, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for KLRS?

DilutionWatch tracks 25 SEC filing types for KLRS including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect KLRS shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For KLRS, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for KLRS tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for KLRS. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

KLRS Dilution Risk Score: 73/100 (HIGH)

Score Breakdown

📋 Offering Ability

80

💰 Cash Runway

65

📊 Float Risk

70

⚠️ Warrant Exposure

15

🔄 Convertible Debt

40

Dilution Forecast

☀️

Clear

No significant dilution signals

model est. 10%

💰 Capital Raise model 15%

• Under 12 months cash (12mo)

📉 Score Deterioration model 10%

• Score in HIGH risk zone (73/100)

🔔 Track KLRS — Get forecast alerts →

Market Data

Market Cap$125.39M

Shares Outstanding23.80M

Float6.57M

Cash$93.54M

DebtN/A

Short InterestN/A

Institutional Holdings

QoQ: ↑ 5.8% shares (2026Q1 vs prior)

58 institutional holders · 19.17M shares

#1 SAMSARA BIOCAPITAL, LLC 12.95M shares

#2 RTW INVESTMENTS, LP 1.30M shares

#3 Paradigm Biocapital Advisors LP 700.0K shares

+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest411.7K

Days to Cover1.0

% of Float6.3%

FINRA data as of Jul 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2025-12-31

4 INSIDER TRANSACTION 2026-02-17

4 INSIDER TRANSACTION 2025-12-22

8-K 8K EVENT 2025-12-18

Full SEC filing analysis available with free account →

Recent News

No recent news

Factual KLRS Dilution Snapshot

Kalaris Therapeutics, Inc. (KLRS) has a DilutionScore of 73/100, rated High dilution risk. Score date: August 28, 2026.

Stored outstanding warrants: 800,000.
Recent SEC activity tracked for KLRS: 4 on 2026-02-17; xbrl on 2025-12-31; 4 on 2025-12-22.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.